BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 16159864)

  • 1. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
    Birks EJ; Hall JL; Barton PJ; Grindle S; Latif N; Hardy JP; Rider JE; Banner NR; Khaghani A; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I57-64. PubMed ID: 16159866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis.
    Cullen ME; Yuen AH; Felkin LE; Smolenski RT; Hall JL; Grindle S; Miller LW; Birks EJ; Yacoub MH; Barton PJ
    Circulation; 2006 Jul; 114(1 Suppl):I16-20. PubMed ID: 16820567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
    Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
    J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.
    Hall JL; Birks EJ; Grindle S; Cullen ME; Barton PJ; Rider JE; Lee S; Harwalker S; Mariash A; Adhikari N; Charles NJ; Felkin LE; Polster S; George RS; Miller LW; Yacoub MH
    Eur Heart J; 2007 Mar; 28(5):613-27. PubMed ID: 17132651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
    Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
    George I; Xydas S; Mancini DM; Lamanca J; DiTullio M; Marboe CC; Shane E; Schulman AR; Colley PM; Petrilli CM; Naka Y; Oz MC; Maybaum S
    J Heart Lung Transplant; 2006 Sep; 25(9):1084-90. PubMed ID: 16962470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial insulin-like growth factor-1 and insulin-like growth factor binding protein-3 gene expression in failing hearts harvested from patients undergoing cardiac transplantation.
    Pucci A; Zanini C; Granata R; Ghignone R; Iavarone A; Broglio F; Sorrentino P; Bergamasco L; Rinaldi M; Ghigo E
    J Heart Lung Transplant; 2009 Apr; 28(4):402-5. PubMed ID: 19332270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.
    Birks EJ; Felkin LE; Banner NR; Khaghani A; Barton PJ; Yacoub MH
    J Heart Lung Transplant; 2004 Feb; 23(2):228-35. PubMed ID: 14761771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.
    Latif N; Yacoub MH; George R; Barton PJ; Birks EJ
    J Heart Lung Transplant; 2007 Mar; 26(3):230-5. PubMed ID: 17346624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
    Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
    J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss).
    Gabillard JC; Kamangar BB; Montserrat N
    J Endocrinol; 2006 Oct; 191(1):15-24. PubMed ID: 17065385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.